FDA warns of an increased risk of Guillain-Barré Syndrome following vaccination with the J&J vaccine
The Food and Drug Administration today revised the Janssen COVID-19 vaccine fact sheet for healthcare providers to include a warning of an observed increased risk of Guillain-Barré Syndrome following ...
Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...
As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another effort to improve treatment of the rare condition. Alongside a clinical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback